10-Q: Syra Health Corp. Reports Strong Revenue Growth and Profitability Turnaround

Syra Health Corp. announced a significant shift to profitability in its Q2 2026 report, driven by a 23% year-over-year revenue increase and improved gross margins.

Summary

• Syra Health Corp. reported a net income of $250,242 for the three months ended June 30, 2026, a substantial improvement from a net loss of $63,596 in the same period of 2025.
• For the six months ended June 30, 2026, the company achieved a net income of $491,221, a significant turnaround from a net loss of $535,861 in the corresponding period of 2025.
• Total net revenues increased by 23% to $2,394,423 for the three months ended June 30, 2026, and by 17% to $4,667,943 for the six months ended June 30, 2026.
• Gross profit margin improved to approximately 45% for the three months and 44% for the six months ended June 30, 2026, up from 39% and 35% respectively in the prior year periods.
• Operating expenses saw a net decrease of $1,321 for the three months and a significant decrease of $283,539 for the six months ended June 30, 2026, attributed to cost-saving measures and operational streamlining.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development, with the company transitioning from a net loss to a net income, driven by significant revenue growth and improved gross margins, although continued reliance on external financing remains a concern.

Positives

• Achieved net income of $250,242 for Q2 2026, a significant turnaround from a net loss in Q2 2025.
• Six-month net income of $491,221 marks a strong recovery from the prior year's net loss.
• Revenue growth of 23% for the quarter and 17% for the six-month period.
• Improved gross profit margin to 45% for the quarter and 44% for the six-month period.
• Reduced overall operating expenses by $283,539 for the six-month period through cost management and operational efficiencies.
• Positive cash flow from operations of $643,183 for the six months ended June 30, 2026, up from $85,754 in the prior year.

Negatives

• The company continues to rely on external financing, stating that existing liquidity sources may not be sufficient for the next twelve months.
• Accumulated deficit stands at $9,229,305 as of June 30, 2026, indicating a history of losses.
• Significant customer concentration, with Humana, Inc. accounting for approximately 37% of revenues for the six months ended June 30, 2026.
• Dependence on state, local, and county government budgets for revenue, which are subject to potential pauses or terminations of spending programs.

Risks

• The company may not have sufficient funds to sustain operations for the next twelve months and may need to raise additional cash.
• Delays in new contract awards or cancellations of previous requests for proposals due to government spending reviews could negatively affect revenue, results of operations, and cash flows.
• The company's ability to scale production and distribution capabilities is dependent on its success in raising additional capital.
• Potential for services-related liabilities.
• Reliance on third-party content providers.
• The success of competing products or services.
• The company's ability to expand its organization to accommodate potential growth and retain key personnel.
• The company may incur substantial costs from lawsuits to enforce or protect its intellectual property rights.

Future Outlook

The company anticipates approval for the CMS ACCESS Model in partnership with HealthSync in the near term, which is expected to serve as a durable source of revenue for the next 10 years. However, the company also notes that it may not have sufficient funds to sustain operations for the next twelve months and may require additional financing.

Management Comments

• The company is too early in its development stage to project revenue with a necessary level of certainty.
• In the event sales do not materialize at the expected rates, management would seek additional financing or would attempt to conserve cash by further reducing expenses.
• The company continues to pursue sources of additional capital through debt and financing transactions or arrangements, including equity financing or other means.
• The company's ability to scale production and distribution capabilities and further increase the value of its brands, is largely dependent on its success in raising additional capital.

Industry Context

StockSavvy.ai notes that Syra Health Corp. operates in the competitive healthcare solutions market, focusing on population health, behavioral health, and healthcare workforce development. The company's reported revenue growth and shift to profitability align with broader industry trends of increased demand for integrated healthcare services and digital health solutions, particularly in mental health. However, the company's reliance on government contracts and potential budget constraints present a significant industry-specific risk.

Comparison to Industry Standards

• The reported gross profit margin of 44-45% for the six-month and three-month periods, respectively, appears strong compared to some industry averages for staffing and healthcare services, suggesting efficient cost management relative to revenue.
• The company's transition from net loss to net income is a positive indicator, though its overall accumulated deficit indicates it is still in a growth or turnaround phase compared to more established, consistently profitable healthcare service providers.
• The significant increase in cash from operations is a positive trend, but the overall cash balance and stated need for future financing highlight a common challenge for growth-stage companies in the healthcare sector, where capital investment is often substantial.

Management Changes

Legal Proceedings

• A former employee filed a wrongful termination lawsuit in January 2024, which was settled on January 15, 2025, with no material impact to the Company.

Related Party Transactions

• The Company owes $125,000 in fees payable to directors as of June 30, 2026.
• The Company leases its corporate headquarters from STVentures, LLC, an entity beneficially owned by principal owners and management team.
• The Company incurred $29,800 in IT services from RAD CUBE LLC, an entity beneficially owned by principal owners and management team, for the six months ended June 30, 2026.
• The Company paid $96,769 and $87,002 for recruitment and HR services from NLogix IT Services Private Limited and SKL Demand Private Limited, respectively, which are entities beneficially owned by principal owners and management team, for the six months ended June 30, 2026.

Stakeholder Impact

• Shareholders: The shift to profitability and revenue growth are positive indicators for shareholders, but the ongoing need for capital raises and accumulated deficit present risks.
• Employees: Increased salaries and benefits in Q2 2026 reflect investment in personnel, potentially indicating growth and stability, but cost-control initiatives may also impact headcount.
• Customers: Continued reliance on government contracts and potential budget constraints could impact service delivery and contract renewals.
• Creditors: The company's liquidity position and reliance on future financing could impact its ability to meet debt obligations if capital is not secured.

Next Steps

• Anticipates approval for the CMS ACCESS Model in partnership with HealthSync in the near term.
• Continue to monitor expenditures and cash flow position.
• Seek additional financing or attempt to conserve cash by reducing expenses if sales do not materialize at expected rates.
• Pursue sources of additional capital through debt and financing transactions or arrangements.

Key Dates

Recommendation

The company has demonstrated a significant turnaround in financial performance, moving from net losses to profitability with strong revenue growth and improved margins. However, the persistent accumulated deficit and explicit statements regarding the potential insufficiency of current liquidity and the need for future capital raises introduce considerable risk. While the positive operational trends are encouraging, the financial precariousness warrants a cautious 'hold' stance until greater certainty around sustained profitability and capital structure is established.

Keywords

Healthcare Staffing, Population Health Management, Behavioral Health, Digital Health, Health Education, Revenue Growth, Profitability, Financial Performance